NewsRoom Articles - Page 1263 of 1346

WednesdayFeb 15, 2017 9:00 am

VolitionRx Ltd. (NYSE: VNRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

VolitionRx (NYSE: VNRX) is a clinical-stage life sciences company focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is involved in the development of 28 epigenetic NuQ blood assays based on its Nucleosomics biomarker discovery platform. VolitionRx develops two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer by detecting nucleosomes containing specific histone variants. The company also develops 17 blood assays in the NuQ-M family to detect cancer by detecting nucleosomes containing…

WednesdayFeb 15, 2017 9:00 am

Auxilio, Inc. (AUXOD) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Auxilio (OTCQB: AUXOD) provides complete document workflow solutions and IT security services to healthcare organizations across the United States. The company has helped its clients save more than $80 million since 2004 by providing solutions which lower costs, improve operational efficiency and enhance security. Auxilio’s iPLATFORM, an intelligent workflow automation suite delivers a customer driven, vendor neutral approach to secure patient health information, reduce waste and drive additional savings opportunities. Auxilio serves a national portfolio of nearly 220 hospital campuses and manages over 1.5 billion documents annually from over 90,000 devices supporting over 280,000 caregivers. For more information, visit the…

WednesdayFeb 15, 2017 9:00 am

Northwest Biotherapeutics (NWBO) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Northwest Biotherapeutics (OTCQB: NWBO) is focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe. The company's lead program is a 331-patient phase III trial in newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer, and is an "orphan disease." Northwest is also pursuing a phase I/II trial with DCVax-Direct for all types of inoperable solid tumor cancers. It has completed the 40-patient phase I portion of the…

WednesdayFeb 15, 2017 8:30 am

Marijuana Industry Acquisitions on the Rise as Companies to Diversify Portfolios, Increase Revenue Streams

The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics as well as the legalization of both medicinal and recreational use in a growing number of states. As a result, M&A activity in the market is heading toward exponential growth as well. Acquisitions help public companies diversify their portfolios and revenue streams while providing private companies access to more financing. Public companies such as SinglePoint, Inc. (SING) (SING Profile), Vinergy Resources Ltd. (VNNYF) and ChineseInvestors.com, Inc. (CIIX) have already initiated or completed such acquisitions, encouraged by the significant growth…

WednesdayFeb 15, 2017 8:30 am

Omni-Channel Payment Processors Embrace the Times

To a greater extent than ever before, consumers are looking for a higher level of convenience throughout every step of the purchase process, from item search and selection to payment and delivery. For many, “faster and sooner” seems to be the preferred choice, especially when it comes to making payments. Tech-savvy consumers, in particular, have increasingly adopted the option of paying via mobile devices, a feature made available thanks to innovations from companies like Net Element, Inc. (NETE) (NETE Profile), PayPal, Inc. (PYPL), Apple, Inc. (AAPL) and Square, Inc. (SQ), and the development of which is driving the rise of…

WednesdayFeb 15, 2017 8:30 am

Capstone Turbine (NASDAQ: CPST) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Capstone Turbine (NASDAQ: CPST) develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications worldwide. The company offers microturbine units, subassemblies, components and various accessories for applications, including cogeneration comprising combined heat and power (CHP) and integrated CHP, as well as combined cooling, heat and power; and renewable energy, natural resources, and critical power supply. Its microturbines are also used as battery charging generators for hybrid electric vehicle applications. For more information, visit the company website at www.capstoneturbine.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

WednesdayFeb 15, 2017 8:30 am

AcelRx Pharmaceuticals (NASDAQ: ACRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

AcelRx Pharmaceuticals (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. An NDA for DSUVIA (sufentanil sublingual tablet, 30 mcg) was recently submitted to the FDA for review. The company's follow on product, ZALVISO® (sufentanil sublingual tablet system), designed for the management of moderate-to-severe acute pain in adult patients in the hospital setting, is currently enrolling patients in a phase 3 clinical trial, IAP312. For more information, visit the company's website at www.acelrx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

WednesdayFeb 15, 2017 8:30 am

CombiMatrix Corp. (NASDAQ: CBMX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

CombiMatrix (NASDAQ: CBMX) provides best-in-class molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. The company specializes in pre-implantation genetic diagnostics and screening, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix’s testing focuses on advanced technologies, including single nucleotide polymorphism (“SNP”) chromosomal microarray analysis (“CMA”), next generation sequencing (“NGS”), fluorescent in situ hybridization (“FISH”) and high resolution karyotyping. For more information, visit the company’s website at www.combimatrix.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

TuesdayFeb 14, 2017 1:22 pm

Singlepoint, Inc. (SING) Helping Cannabis Businesses Accept Transactions in a Secure and Legal Way

Despite a total of 28 states having now legalized marijuana in some form, the U.S Drug Enforcement Administration still classifies cannabis as a Schedule 1 substance, alongside heroin and LSD. With this mind, it has been hard for the banking industry to support legal marijuana businesses. Because such businesses have fewer options in opening bank accounts with national banks, they are pressured to accept cash payments, making them vulnerable to all of the issues associated with operating a cash business. Cash transactions make cannabis businesses prime targets for theft and break-ins, not to mention the gap left open for certain…

MondayFeb 13, 2017 11:36 am

SeeThruEquity Projects Moxian, Inc. (NASDAQ: MOXC) Revenues at Greater Than $40 Million by FY2019

SeeThruEquity initiated coverage of Moxian, Inc. (NASDAQ: MOXC) on February 8, 2017, projecting that the China-based company will achieve annual revenues of more than $40 million by FY2019 alongside EBITDA of $17.456 million. The investment research firm set a price target of $4.50 for the company’s stock (http://nnw.fm/Kb4Rn). Moxian is focused on the $48 billion (1H2017) O2O market, according to the SeeThruEquity report, quoting investment materials from the company. Moxian’s platform, Moxian+, targets small- and medium-sized businesses in the O2O market in China. Moxian offers consumers the ability, through mobile, social media, and online channels, to purchase online and pay…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

VolitionRx Ltd. (NYSE: VNRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Auxilio, Inc. (AUXOD) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Northwest Biotherapeutics (NWBO) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Marijuana Industry Acquisitions on the Rise as Companies to Diversify Portfolios, Increase Revenue Streams

Omni-Channel Payment Processors Embrace the Times

Capstone Turbine (NASDAQ: CPST) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

AcelRx Pharmaceuticals (NASDAQ: ACRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

CombiMatrix Corp. (NASDAQ: CBMX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Singlepoint, Inc. (SING) Helping Cannabis Businesses Accept Transactions in a Secure and Legal Way

SeeThruEquity Projects Moxian, Inc. (NASDAQ: MOXC) Revenues at Greater Than $40 Million by FY2019

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search